265 related articles for article (PubMed ID: 20525460)
1. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.
Baker R; Bateman I; Donaldson C; Jones-Lee M; Lancsar E; Loomes G; Mason H; Odejar M; Pinto Prades JL; Robinson A; Ryan M; Shackley P; Smith R; Sugden R; Wildman J;
Health Technol Assess; 2010 May; 14(27):1-162. PubMed ID: 20525460
[TBL] [Abstract][Full Text] [Related]
2. The social value of a QALY: raising the bar or barring the raise?
Donaldson C; Baker R; Mason H; Jones-Lee M; Lancsar E; Wildman J; Bateman I; Loomes G; Robinson A; Sugden R; Prades JL; Ryan M; Shackley P; Smith R
BMC Health Serv Res; 2011 Jan; 11():8. PubMed ID: 21223540
[TBL] [Abstract][Full Text] [Related]
3. Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients.
Reckers-Droog V; van Exel J; Brouwer W
Value Health; 2021 Aug; 24(8):1182-1192. PubMed ID: 34372984
[TBL] [Abstract][Full Text] [Related]
4. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
5. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
6. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
Nielsen JS; Gyrd-Hansen D; Kjaer T
Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
[TBL] [Abstract][Full Text] [Related]
7. Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A; Goto R; Yoneyama-Hirozane M
J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
[No Abstract] [Full Text] [Related]
8. Value of a QALY and VSI estimated with the chained approach.
Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
10. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
[TBL] [Abstract][Full Text] [Related]
11. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
12. The value of a QALY: individual willingness to pay for health gains under risk.
Bobinac A; van Exel J; Rutten FF; Brouwer WB
Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
[TBL] [Abstract][Full Text] [Related]
13. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
15. Comparing WTP values of different types of QALY gain elicited from the general public.
Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
18. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
19. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.
Ratcliffe J; Couzner L; Flynn T; Sawyer M; Stevens K; Brazier J; Burgess L
Appl Health Econ Health Policy; 2011; 9(1):15-27. PubMed ID: 21033766
[TBL] [Abstract][Full Text] [Related]
20. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
Olofsson S; Norrlid H; Persson U
J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
